CBD Co. Zynerba, Investors Aim To Settle Drug Trial Claims
CBD drugmaker Zynerba Pharmaceuticals and a proposed class of shareholders told a federal judge in Philadelphia that they expect to soon finalize details of a settlement that, if approved, will end...To view the full article, register now.
Already a subscriber? Click here to view full article